Latest news from ProtonDx
ProtonDx tackles malaria diagnosis
Fri, April 29th 2022
Lacewing, the futuristic lab-on-a-chip, diagnostic tool is one of eight initiatives promoted by Imperial College London to mark Malaria Day, 25 April, in order to demonstrate the College’s deep commitment to conquering malaria. Lacewing is being developed for health care applications by Imperial spin out company ProtonDx based at the College’s Translation and Innovation HUB (I-HUB), White City Campus.
Read article
Dragonfly goes Olympic
Tue, April 26th 2022
The Dragonfly Respiratory Diagnostic Panel was utilised by the Team GB clinical staff with great success to test Great Britain's athletes at the 2022 Olympic Winter Games in Beijing.
Read article
Higher risk for patients with flu and Covid-19
Mon, March 28th 2022
People infected by Covid-19 and influenza face four times the risk of requiring a ventilator and twice the risk of death. Diagnosis of which respiratory viruses are infecting the patient is crucial especially as there is no increased risk of severe illness for those with both Covid-19 and RSV or other respiratory viruses.
Read article
Lateral flow tests found wanting
Tue, March 1st 2022
Research by Imperial College London suggests that lateral flow tests miss a substantial number of COVID-19 infections, particularly for people without symptoms emphasising the need for rapid, sensitive, accurate and portable tests.
Read article
Antimicrobial Resistance crisis needs better diagnostics
Tue, February 22nd 2022
“Better, faster diagnostics will be central to tackling Antimicrobial Resistance in the future,” said ProtonDx Founder & Director, Asst Professor Jesus Rodriguez-Manzano, at a recent FORUM event organised by the Academy of Medical Sciences
Read article
ProtonDx CEO award for inspiration
Mon, December 20th 2021
ProtonDx CEO, Professor Pantelis Georgiou has won an award for his inspirational work from his colleagues in the Department of Electrical and Electronic Engineering, Imperial College London
Read article
Imperial Biomedical hub officially opened
Mon, December 6th 2021
ProtonDx is privileged to have secured office space in the prestigious Translation and Innovation Hub (IHUB) at White City campus of Imperial College London.
Read article
Best of British recognises ProtonDx
Thu, September 23rd 2021
The work of the ProtonDx team has been recognized in Best of British a government publication produced jointly with Malaria NO MORE.
Read article
ProtonDx CEO appointed Professor of Biomedical Electronics
Wed, September 22nd 2021
CEO of ProtonDx, Dr Pantelis Georgiou, was promoted to Professor of Biomedical Electronics in the annual promotion round at Imperial College London, one of only six to achieve this accolade this year.